News
Season’s Greetings from EPHMRA!
Firstly, we want to take a moment to thank each and every one of our valued members for their dedication, collaboration, and contributions throughout the year.
We wish you all a great Festive Season and hope you are able to enjoy some time with family and friends.
Looking forward to reconnecting again in 2025.
EPHMRA Webinar - Social Listening in Pharma.
After a well-attended webinar in November we are bringing this event to you again in 2022.
Join us on 1st February 2022 at 14.15 UK time with guest speaker; Yannick Rieder, Market Research & Competitive Intelligence Manager, Janssen-Cilag GmbH and Convenor; An-hwa Lee, Director at Research Partnership and member of the LDC.
Happy New Year
...to all EPHMRA colleagues and member companies. Hope you all have a very good 2022 and stay safe and well.
It’s been a challenging past 12 months but let's get 2022 off to the best start we can!
EPHMRA March 2022 News
Contributions by 15 January please. For our March Newsletter please do send us your company news, this can be about people or services you would like to announce. We produce our news in PDF format for the web site and we have over 2500 contacts on our international healthcare market research database.
MR Excellence Awards 2022
Submissions for the MR Excellence awards are to be submitted by 28 February. EPHMRA is delighted to announce the launch of the EPHMRA MR Excellence Awards for 2022 in recognition of the amazing work our members and colleagues do.
Take a look at our December News update just published.
Find out more here
The News features articles from member companies:
1. Making the Healthy Habits Stick – Borderless Access
2. Virtual vs. in-person research: In defence of a hybrid approach – Branding Science
Here's a great resource from ADM in Germany - to support those working in our industry: https://www.adm-ev.de/en/standards-guidelines/#anker2
These guidelines provide the principal requirements of Pharmacovigilance (PV) reporting for individuals or organisations involved in market research (MR) activities within the healthcare industry. This includes those working for a Marketing Authorisation Holder (MAH), Market Research Organisation (MRA) or other organisations involved in MR activities. It applies to employees and contractors working with or for a MAH, MRA or other organisations engaged in MR.
